Nov 16, 2022 / NTS GMT
Presentation
Nov 16, 2022 / NTS GMT
=====================
Corporate Participants
=====================
* René C. Goehrum
BioSyent Inc. - Chairman, CEO & President
=====================
RenéC. Goehrum - BioSyent Inc. - Chairman, CEO & President
Hello, and welcome to the Q3 and YTD 2022 Results Presentation for BioSyent Inc.. My name is René Goehrum, and I'm the President and CEO of the company.
I want to start today's presentation with a look at our sales, EBITDA and net income after tax for the quarter. And you'll see on the slide presented the last 3 years for those periods of time. In the quarter, our sales were just under $6.8 million, representing a 2% increase to the year ago quarter.
And I'd just like to break that down a little bit for you. You're aware that at the beginning of this year, we discontinued 3 products under 2 brands, and that requires a little bit of explanation when comparing business performance. So our Canadian Pharmaceutical business was down 1% for the quarter versus a year ago without
Q3 2022 Biosyent Inc Earnings Presentation Transcript
Nov 16, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers